We are live on ! Find out more
FCH

Freestone Capital Holdings Portfolio holdings

AUM $3.3B
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
-12.54%
1 Year Est. Return
+21.14%
3 Year Est. Return
+69.84%
5 Year Est. Return
+90.02%
10 Year Est. Return
+579.74%
AUM
$1.48B
AUM Growth
-$14.4B
Cap. Flow
-$14.2B
Cap. Flow %
-960.04%
Top 10 Hldgs %
22.09%
Holding
477
New
85
Increased
144
Reduced
164
Closed
69

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$24.3M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$21.3M
3
VSS icon
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
+$14.1M
4
CWI icon
State Street SPDR MSCI ACWI ex-US ETF
CWI
+$13.6M
5
AMLP icon
Alerian MLP ETF
AMLP
+$13.5M

Top Sells

Rank Stock Value
1
SYNT
Syntel Inc
SYNT
+$26.5M
2
ESRX
Express Scripts Holding Company
ESRX
+$21.9M
3
HRB icon
H&R Block
HRB
+$17.9M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$11.5M
5
IHG icon
InterContinental Hotels
IHG
+$11.1M

Sector Composition

Rank Sector Weight
1 Technology 15.45%
2 Healthcare 11.45%
3 Communication Services 8.68%
4 Consumer Discretionary 8.36%
5 Industrials 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JCI icon
26
Johnson Controls International
JCI
$85.6B
$12.9M 0.88%
+14,187
New +$468K
CWI icon
27
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.73B
$12.9M 0.87%
+591,566
New +$13.6M
VEU icon
28
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$12.8M 0.87%
281,429
+193,934
+222% +$9.31M
CI icon
29
Cigna
CI
$79.6B
$12.5M 0.85%
65,864
+47,841
+265% +$9.98M
GILD icon
30
Gilead Sciences
GILD
$167B
$12.4M 0.84%
198,522
-123,325
-38% -$8.62M
AMLP icon
31
Alerian MLP ETF
AMLP
$12.9B
$12.3M 0.83%
280,767
+274,277
+4,226% +$13.5M
PNR icon
32
Pentair
PNR
$10.8B
$11.9M 0.81%
314,707
+228,102
+263% +$9.22M
IVV icon
33
iShares Core S&P 500 ETF
IVV
$871B
$11.1M 0.75%
+44,057
New +$12M
VWO icon
34
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$11M 0.74%
287,858
-77,206
-21% -$2.99M
COR icon
35
Cencora
COR
$62.2B
$11M 0.74%
147,329
-59,410
-29% -$5.12M
GSK icon
36
GSK
GSK
$108B
$10.6M 0.72%
222,833
+4,991
+2% +$246K
BIIB icon
37
Biogen
BIIB
$30.4B
$10.4M 0.71%
34,698
-15,269
-31% -$4.87M
VT icon
38
Vanguard Total World Stock ETF
VT
$76.3B
$10.4M 0.7%
158,541
+151,755
+2,236% +$10.6M
URTH icon
39
iShares MSCI World ETF
URTH
$7.93B
$10.3M 0.7%
+130,896
New +$11.1M
NVO
40
Novo Nordisk
NVO
$225B
$10.2M 0.69%
442,242
+1,554
+0.4% +$34.5K
CHL
41
DELISTED
China Mobile Limited
CHL
$10.1M 0.68%
209,594
-8,087
-4% -$389K
ABBV icon
42
AbbVie
ABBV
$465B
$9.01M 0.61%
97,730
-11,366
-10% -$1,000K
BT
43
DELISTED
BT Group plc (ADR)
BT
$8.73M 0.59%
574,083
-44,599
-7% -$710K
AEIS icon
44
Advanced Energy
AEIS
$10.9B
$8.61M 0.58%
200,458
+5,371
+3% +$239K
XLNX
45
DELISTED
Xilinx Inc
XLNX
$8.53M 0.58%
+8,622
New +$721K
DLX icon
46
Deluxe
DLX
$1.25B
$8.52M 0.58%
221,757
-21,921
-9% -$1.05M
MDY icon
47
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$8.36M 0.57%
27,632
+26,504
+2,350% +$8.82M
TARO
48
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$8.18M 0.55%
96,627
-44,092
-31% -$4.25M
TLK icon
49
Telkom Indonesia
TLK
$14.2B
$8.16M 0.55%
311,534
-35,660
-10% -$906K
TXN icon
50
Texas Instruments
TXN
$253B
$8.04M 0.54%
85,095
+3,193
+4% +$309K
1
2
3 4 5

Similar funds

SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.27B AUM 25.8% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
AFG
Atomi Financial Group New York $3.26B AUM 32.85% 1-Year Est. Return

Freestone Capital Holdings's Q4 2018 Portfolio in Review

As of Q4 2018, Freestone Capital Holdings held 477 positions worth $1.48B, down 91% from $15.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Freestone Capital Holdings withdrew a net $14.2B in Q4 2018, closing 69 positions and reducing 164 holdings. Its most notable exit was Syntel Inc, an estimated $26.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 2% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Freestone Capital Holdings opened a new position in Vanguard FTSE All-World ex-US Small-Cap Index Fund worth $13.2M.

  • Freestone Capital Holdings's largest Q4 2018 buy was Vanguard FTSE All-World ex-US Small-Cap Index Fund: 139,064 shares worth $13.2M.
  • Freestone Capital Holdings added most to Vanguard S&P 500 ETF in Q4 2018, an estimated $24.3M increase.
  • Freestone Capital Holdings's biggest Q4 2018 reduction was H&R Block, cutting an estimated $17.9M.
  • Freestone Capital Holdings fully exited Syntel Inc in Q4 2018, selling an estimated $26.5M.
  • Freestone Capital Holdings's ten largest holdings make up 22% of its $1.48B portfolio in Q4 2018.
  • Freestone Capital Holdings opened 85 new positions and closed 69 in Q4 2018.
  • Freestone Capital Holdings's portfolio value fell 91% quarter-over-quarter to $1.48B.

Based on Freestone Capital Holdings's 13F filing for Q4 2018, filed 12 Feb 2019.